BMP6 and ocular melanoma: PCNA expression increased in the OM control group and decreased in the BMP6-treated group relative to the d0 reference, and BMP6 treatment resulted in significant down-regulation compared to control OM at both 4 and 6 weeks (Fig. 7C; n = 6, p < 0.0001).